Wells Fargo’s Bio-Techne TECH Stock Holding History

Wells Fargo’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.25M	Buy	+24,000	New	+$1.44M	﹤0.01%	3604

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wells Fargo's TECH Position: Q1 2026 in Review

Wells Fargo increased its Bio-Techne (TECH) stake by 16% in Q1 2026, buying an estimated $1.96M and bringing the position to 243,062 shares worth $12.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1849.

Wells Fargo first reported a position in TECH in Q2 2013 and has held it in 52 quarters since. The position peaked at $126M in Q3 2021. 583 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

Wells Fargo held 243,062 shares of Bio-Techne worth $12.7M as of Q1 2026.
Wells Fargo bought 32,645 Bio-Techne shares in Q1 2026, an estimated $1.96M.
Bio-Techne made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #1849 holding.
Wells Fargo first reported a position in Bio-Techne in Q2 2013 and has held it in 52 quarters since.
Wells Fargo's Bio-Techne position peaked at $126M in Q3 2021.
583 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.